menu
    • menu

    Company profile for OUTLOOK PHARMS

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Outlook Pharmaceuticals Inc. engages in the development of drugs for the treatment of nervous system disorders. The company is based in Cincinnati, Ohio.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OUTLOOK PHARMSUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    747 Tusculum Ave Cincinnati, Ohio 45226-1769 United States
    Telephone
    Telephone
    +1 513-533-3379
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    --
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Outlook Therapeutics Receives FDA Agreement for 3 Special Protocol Assessments
    Outlook Therapeutics Receives FDA Agreement for 3 Special Protocol Assessments

    03 Dec 2019

    // GLOBE NEWWIRE

    https://www.globenewswire.com/news-release/2019/12/03/1955500/0/en/Outlook-Therapeutics-Receives-FDA-Agreement-for-Three-Special-Protocol-Assessments-for-Additional-Planned-Clinical-Trials-of-ONS-5010.html

    GLOBE NEWWIRE
    03 Dec 2019
    Share Share
    Outlook Therapeutics closes enrolment in Phase III wet AMD study
    Outlook Therapeutics closes enrolment in Phase III wet AMD study

    21 Aug 2019

    // CLINICALTRIAL SARENA

    https://www.clinicaltrialsarena.com/news/outlook-therapeutics-phase-iii-wet-amd/

    CLINICALTRIAL SARENA
    21 Aug 2019
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search